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ABSTRACT
Background: Malaria prevention strategies have significantly reduced the prevalence 
of malaria in pregnant women in several studies done in malaria endemic regions. 
Objective: To determine the effectiveness of Intermittent preventive treatment with 
sulphadoxine-pyrimethamine and Insecticide treated nets on the prevention of malaria 
in pregnancy in a non-malaria endemic area.
Design: Comparative study. 
Setting: Kapsabet District Hospital in Nandi County.
Subjects: One hundred and fourty three non-randomised pregnant women were 
followed through the Antenatal clinic before 28 weeks gestation until delivery and 
compared with records of 600 pregnant women ( non-intervention arm), who attended 
ANC and delivered at the hospital. 
Results: The incidence of malaria infection in pregnancy was 21% in the non-intervention 
group compared with 8% in the intervention group, (p-value 0.000). The incidence of 
low birth weight was 12.5% in the non-intervention group compared with 5.6% in the 
intervention group (p-value 0.018); with a reduction of low birth weight by 50% in the 
intervention group.  The incidence of Still births was 6% in the non-intervention group 
and 1.4% in the intervention group (p-value 0.025). There were two (0.3%) cases of 
maternal mortality in the non-intervention group and no mortality in the intervention 
group which was statistically not significant but clinically significant. 
Conclusion: The use of intermittent preventive treatment with sulphadoxine-
pyrimethamine and Insecticide Treated Nets is effective in prevention of malaria in 
pregnancy in non-malaria endemic region and is associated with reduction of adverse 
pregnancy outcome. There is therefore a need of up scaling the use of sulphadoxine-
pyrimethamine during pregnancy, and availing subsidised long lasting insecticide 
treated bed nets to pregnant women countrywide.
INTRODUCTION 
In Africa it is estimated that twenty five million 
pregnant women are at risk of malaria infection 
during the antenatal period (1-3). Malaria is a 
febrile illness caused by the plasmodium falciparum 
,vivax, ovale and malaria. The plasmodium falciparum 
contributes up to 98% of malaria cases. In moderate 
to high transmissions areas the point prevalence 
of malaria infection in pregnancy (peripheral or 
placental) in all gravidae is estimated at 27.8% (4). 
The pregnant woman is most at risk especially in the 
second trimester due to the tendency of the malaria 
parasite hiding in the placental bed (5,6) . Pregnancy 
associated malaria results in several adverse outcomes 
which are; maternal anaemia, low birth weight (Lbwt), 
preterm deliveries and congenital malaria, perinatal 
and maternal death. Maternal death attributable to 
malaria from direct and indirect causes in low/high 
transmission areas is between 93-320/100,000 live 
births are findings from studies done in high endemic 
areas such as Mozambique and Gambia (7,8). In 
malaria endemic regions, malaria contributes to 70% 
of Intra Uterine Growth Restriction (IUGR) and 36% of 
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preterm deliveries, sever anaemia 26% (9,10),  20% of 
Low birth weight (<2500g) (4, 11). In high transmission 
areas of Africa, malaria induced Lbwt is estimated 
to be responsible for between  62,000-363,000 infant 
deaths every year which translates to 3-17 deaths 
per 1,000 live births (12). In malaria endemic region 
transmissions are common throughout the year 
(perennial). In Kenya there are two regions; around 
Lake Victoria and along the coast (13). While in non-
malaria endemic regions there is limited transmission 
throughout the year but potential for epidemic 
outbreaks such as the highland districts of Kenya 
(13).  World health organization (WHO) recommends 
a three-pronged approach to the prevention and 
management of malaria in pregnancy, which are: Two 
doses of sulphadoxine –pyrimethamine (SP) during 
pregnancy, Use of insecticide treated nets (ITNs) and 
Case management (14).
 Meta-analysis  of intervention trials suggest that 
successful prevention of malaria infections decrease 
the risk of maternal anaemia by 38%, Lbwt by 43%, 
and perinatal mortality by 27% (1). Intermittent 
preventive treatment with SP (IPT-SP) was found 
to reduce the prevalence of maternal parasitaemia 
to 10.4% in a study done in Nigeria (15). In other 
countries in Africa it was found out that use of ITNs 
in pregnancy was beneficial to maternal and foetal 
outcome but is not significant on the reduction of 
the prevalence of malaria (16). The Government of 
Kenya (GOK) policy on prevention and management 
of malaria in pregnancy is: To ensure that all pregnant 
women living in malaria areas will have access to two 
SP doses at 16-27 weeks and 28-36 weeks, to increase 
access to ITNs amongst people at risk especially 
young children and pregnant women, and Effective 
community based communication to encourage 
prompt treatment of fever (14). The GOK targets by 
2006 were: To have 60% of pregnant women receiving 
two SP in second and third trimester (23). There are 
variations among African countries (Kenya included), 
as follows, 33-93% for one dose and 24-68% for the 
two or more doses (1). Another target was to have 
80% of fever or anaemia cases to be appropriately 
managed at ANC  services and to achieve over  60% 
of pregnant women to sleep under treated nets during 
their confinement. By December 2006, 50% of pregnant 
women were using ITNs (14,17). 
 Studies at malaria-endemic regions of Kisumu 
and Kilifi had demonstrated significant reduction 
in incidence of anaemia among pregnant women 
following administration of IPT-SP. There is also 
strong evidence to suggest decreased incidence of 
LBwt following IPT-SP (18).  The study in Bondo 
demonstrated that IPT-SP is effective in controlling 
maternal anaemia in areas of high transmissions 
especially among primigravidae, however the use 
of ITNs alone showed a substantial protective effect 
against anaemia in primigravidae (19).
 Evidence from studies in Siaya, Kenya, confirms 
findings   from Gambia that ITNs may confer some 
protection against malaria infection among pregnant 
women (20). Evidence from other areas in Africa is 
less conclusive, but areas of epidemic risk in South 
East Asia have shown significant protection against 
anaemia and low birth weight through the use of 
ITNs by pregnant women (21). 
 GOK implemented the IPT-SP policy in the year 
1998 and currently the coverage is 33-93% in malaria 
prone areas (22). ITNs access was equally improved in 
the year2004/2005 by provision of subsidised treated 
nets to children and pregnant women through ANC 
and in the year 2006 there was distribution of ten 
million free ITNs to vulnerable groups in malaria 
prone districts (23). Therefore a larger proportion of 
pregnant women are on IPT-SP and more than half of 
them sleep under treated nets in most of malaria prone 
districts. The study was conducted in Central Nandi 
district where IPT-SP coverage was 88.5% for both 
first and second doses.   The current national malaria 
guidelines on prevention of malaria during pregnancy 
recommends IPT-SP and ITN for all pregnant women 
in malaria endemic and non-malarial endemic 
regions. However, the effect of this in non- malaria 
endemic regions has not been objectively evaluated. 
This study aims to determine the effectiveness of the 
interventions. Understanding the effectiveness and 
dynamics of the interventions on malaria during 
pregnancy in this region will help to revise malaria 
preventive approaches during pregnancy.
 Other studies have shown that in Africa 11.4% 
(100,000) of all infant deaths in endemic areas is 
caused by malaria associated Lbwt (24), the effect 
of Lbwt is greatest in infants born to primigravida 
contributing to 17.6% of neonatal deaths and 9.8% of 
infant deaths (25). Nine hospital based studies showed 
that placental malaria was associated with twice the 
risk for stillbirth (26). More recent reports from both 
malaria endemic and non-endemic areas show higher 
prevalence of congenital malaria ranging from 8% 
to 33%, these were detected by use of PCR (27,28). 
The Abuja declaration of April 2000 at the Africa 
head of states summit on `Roll Back Malaria`(RBM) 
recognised the disease and its economic burden 
that malaria places on hundreds of people and 
the barriers it contributes to development and 
alleviation of poverty (27). There is little information 
on the effectiveness of the intervention on Malaria 
prevention in pregnancy in the non-endemic areas. 
The objective of the study was to determine the 
effectiveness of Intermittent preventive treatment 
with sulphadoxine-pyrimethamine and Insecticide 
treated nets on the prevention of malaria in pregnancy 
in a non-malaria endemic area. The study participants 
were fully informed about the study before being 
requested to participate. An informed consent was 
obtained from all the participants recruited into the 
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study. Approval was obtained from Kenyatta National 
Hospital / University of Nairobi Ethics and Research 
Committee. Permission was sort for and granted by 
the hospital medical superintendent to conduct the 
study.
        MATERIALS AND METHODS   
   
Study Design: This was pre and post IPT/ITN/IRS 
Intervention comparison study, where a group of 
pregnant women who received IPT and used ITNs 
were followed through the antenatal clinic until they 
delivered and compared with records of other group 
of women who attended ANC and delivered at the 
hospital before the implementation of intervention 
strategies.
Study population: Pregnant women attending antenatal 
care (ANC) at Kapsabet District Hospital. The average 
attendance is 300 mothers daily. With a population 
of 18,000  pregnant women annually. 
Study Duration. The study was conducted between 
February and August 2010. 
Study Area: The study was conducted at Kapsabet 
district hospital, in Nandi County, it has a catchment 
population of 364,000. The hospital has 4500 deliveries 
each year with an estimated 40% home deliveries. 
The high malaria transmissions season is February 
to August annually.
Inclusion criteria: Consenting pregnant women who 
presented to ANC in the first and second trimester 
before 28 and weeks of pregnancy. Exclusion 
criteria, decline to provide informed consent, clients 
commencing ANC after 28 weeks of pregnancy clients 
known to be allergic to SP.
Sampling procedure:  Mothers attending antenatal clinic 
(ANC), who consented  to the study and met the 
inclusion criteria were recruited consecutively until 
the desired sample size was reached, the consenting 
mothers were then followed antenatal till delivery
Sample size: The minimum sample size was calculated 
using the formula for comparative studies, 143 women 
were recruited into the study for the intervention 
group and 600 for the non-intervention group was 
the number of pregnant women who delivered within 
the study period.  
Study tools and procedure: Three research assistants 
who were qualified nurses were recruited and trained 
on the study. The questionnaire was pretested before 
the commencement of the study, recruitment of the 
clients was done sequentially till the desired sample 
size was reached.  Recruitment of study participants 
was carried out after meeting the eligibility criteria. 
The questionnaire was administered to the study 
participants by the research assistants and the 
principal investigator. Part A of the questionnaire 
was administered at recruitment and during 
administration of the second dose of SP which was 
at the ANC and was directly observed (DOTS). 
Recruited woman were advised to seek treatment at 
the District hospital or nearby health facility should 
they fall sick. Documentation of malaria infection 
were based on those who were diagnosed with clinical 
malaria and put on anti-malarial drugs and those who 
tested positive for malarial parasites. Women were 
advised to deliver at the District hospital, and if they 
did deliver elsewhere then they were to report to the 
ANC within one week of delivery.  Study participants 
attended ANC routinely and at delivery. Part B: of the 
questionnaire was administered and data collection 
form filled. Records and files of 600 pregnant women 
who attended and delivered at the hospital were 
reviewed and data on those diagnosed with malaria, 
birth weights, still births, and maternal mortality 
from malaria was documented on non-intervention 
data collection form. Some of the records were found 
not to have complete entries. The challenges during 
the data collection included mothers willingness 
to give details of their residential environment, 
irregular antenatal care visits, these were addressed 
by informing the mothers that the study will benefit 
the community.   
Data analysis: Data were checked and cleaned before 
entering into software programme for social science 
research (SPSS version 16). Analysis was done using 
SPSS and excel. Chi-square and student t-test were 
used to test the relationships between the use and 
non-use of treated nets and malaria infection, malaria 
infection and pregnancy outcome 
Study limitations: The use of ITNs was assessed 
through self reporting and the consistency of ITN 
use could not be verified. Use of ITNs is affected by 
the type of housing which were not similar for all 
the participants.
RESULTS
There were 143 who used the ITN/ITP and 600 
hundred were non-users.
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Table 1
Socio-demographic characteristics of the study participants. 
   STUDY GROUPS     
Characteristic   Non- Intervention (%) Intervention (%) Total (%) P- Value 
 <15 4 (0.76) 0 (0) 4 (0.5)  
 15-24 357 (59.5) 73 (51) 430 (57.9) 
 25-34 192 (32) 61 (42.7) 253 (34.1) 
 35-44 44 (6.3) 9 (7.3) 53 (7.1) 
 45+ 3 (0.5) 0 (0) 3 (0.4) 
Age (yrs) Total 600 (100) 143 (100) 743 (100) 0.13
  0 357 (59.5) 83 (58) 440 (59)  
 1 141 (23.5) 30 (21) 171 (23) 
 2 72 (12) 21 (14.7) 93 (12.5) 
 3+ 30 (5) 9 (6.5) 39 (5.5) 
Parity Total 600 (100) 143 (100) 743 (100)  0.11
 1 274 (45.2) 0 (0) 274 (37.2)  
 2 278 (46.3) 65 (45.6) 343 (45.8) 
 3+ 48 (8.0) 78 (54.4) 126 (17) 
ANC Visits  Total  600 (100) 143 (100) 743 (100)  0.001
Table 1 shows the mean age for the non-intervention 
group to be 24 years, while for the intervention 
group was 25 years. The study participants were 
of parity 0 (59.5% in the non- intervention and 58% 
in the intervention group). Participants in the non- 
intervention group had less ANC visits, 45.2% had 
one visit, 46.3% had two visits and  only 8% had 
more than two  visits, compared with the intervention 
group where most of the participants had more than 
two visits (54.4%)  
Figure 1
Gestation at administration of first dose of SP (Intervention group)
Figure 1, Shows that the mean gestational age at administration of first SP dose was at 26 weeks 
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Figure 2
Gestation at administration of second dose of SP. (Intervention group)
Figure 2, shows that the mean gestational age at administration of second SP dose was at 32 weeks, this is 
within the WHO recommended period (28-36 weeks). 
Figure 3
Methods of malaria prevention. (Intervention  group)
Figure 3, shows malaria protection methods used by the prospective study group (n=143). All the study 
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Table 2
Comparison of pregnancy outcomes between the Non- intervention and the
 Intervention group
 
Pregnancy  Non- Intervention Intervention  P-value  Odds Ratio  95%
out come           (n=600)            IPT/ITNS    Confidence Interval
                                       (n=143)     
Malaria infection
in pregnancy 126(21%) 11(8%) 0.000 0.024 1.7-6.1
Low birth weight 75(12.5%) 8(5.6%) 0.018 0.027 1.1-5.1
Still births  36(6%) 2(1.4%) 0.025 0.014 1.2-16.7
Maternal mortality  2(0.3%) 0(0%) 0.489 ---- 0.78-.84
OR = Odds Ratio, CI = Confidence Interval
Table 2 shows that, the prevalence of malaria was 
21% in the non-intervention group compared with 8% 
in the intervention group.Twelve point five percent 
had low birth weight in the non-intervention group 
compared with 5.6% in the intervention group. Still 
births was more prevalent in the non-intervention 
group (6%) compared with intervention group (1.4%). 
There were two (0.3%) cases of maternal mortality 
in non-intervention group, and no maternal death 
in the intervention group. The mortality was not 
attributable to the malaria infection, but due to 
obstetric haemorrhage. 
Table 3
Correlation of Malaria in pregnancy and Low Birth Weight
  Low Birth Weight( n=83)    
  Non- Intervention  Intervention  Total  P- value
 group  group
 (n=75) (n=8)   
Malaria infection 
in pregnancy.  46(61%) 0 (0%) 46(100%) 
No malaria infection 
in pregnancy.   29(39%) 8(100 %) 37(100%)
Total 75(100%) 8(100%) 83(100%)  0.001
Table 3, shows that 61% of the women in the non-
intervention group who had malaria infection during 
pregnancy also delivered low birth weight babies 
compared to 0% in the intervention group. Thirty 
nine pecent of the women in the non-intervention 
group who had no malaria infection in pregnancy 
also had low birth weight babies compared to 8% in 
the intervention group. 
      
DISCUSSION 
This study found that the incidence of malaria infection 
in pregnancy was 21% in the non-intervention group 
compared to 8% in the intervention group, (p=0.000), 
this is comparable to the study done by Stekette et 
al where the point prevalence of malaria infection 
without interventions was 25% (4) and Falade et al 
who found that the incidence of malaria infection with 
IPT-SP intervention was 10% (28).  The incidence of 
low birth weight was 12.5% in the non-intervention 
group compared to 5.6% in the intervention group 
(p-value 0.018), this represented reduction of low birth 
weight by 50%, which is comparable to the findings of 
Duffy et al, who showed that preventive interventions 
reduced low birth weight by 43% (1).  In this study 61% 
of the women in the non-intervention group who had 
malaria infection during pregnancy also delivered low 
birth weight babies compared to 0% in the intervention 
group. Thirty nine pecent of the women in the non-
intervention group who had no malaria infection in 
pregnancy also had low birth weight babies compared 
with 8% in the intervention group (p=0.001 Table 3). 
There is a significant difference in low birth weight 
between the two groups among those who had no 
malaria infection during pregnancy which could be 
attributed to better antenatal care in the intervention 
group for other causes of low birth weight.    
  The incidence of Still births was 6% in the non-
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intervention group and 1.4% in the intervention 
group (p=0.025, Table 2). This represented a 
reduction in perinatal mortality by 66% which is a 
much better outcome compared to results obtained 
from meta-analysis of intervention trials where 
perinatal mortality was reduced by 27% (1). There 
were two (0.3%) cases of maternal mortality in the 
non-intervention group and no mortality in the 
intervention group. .  
 There was no difference in age and parity 
distributions between the two study groups. Most 
of the study participants had a mean age of between 
24-25 years (60%) in the non-intervention group and 
(51%) in the intervention group. Larger proportions of 
participants (59%) in both groups were primigravida 
which is also the group more susceptible to malaria in 
pregnancy (Table 1). Participants in the intervention 
group had more ANC visits, more than two visits 
(78%) compared with (8%) in the non- intervention 
group (p=0.001, Table 1). The difference in ANC 
visits could be attributed to counselling and follow 
up during antenatal care in the intervention group.  
 In this study the use of intermittent preventive 
treatment SP and insecticide treated nets was 
associated with favourable pregnancy outcome 
(p<0.05, Figure 4). Other factors which could have 
contributed to the favourable change is health 
promotion education on the vector control activities, 
improved awareness on the signs and symptoms 
and early treatment of malaria which accompanied 
social mobilisation during the implementation of 
the interventions in the year 2002. IPT/ITN policy 
is indeed good, but cost implications especially on 
sustainability of ITN provision and development 
of resistance to SP might be challenging in the near 
future. The on going trials of malaria vaccine in Kenya 
is a much more promising intervention.
   
LIMITATIONS OF THE STUDY 
The use of ITNs was assessed through self reporting 
and it was yes or no answer, but the consistency of 
ITN use could not be verified. Use of ITNs is affected 
by the type of residential house which were not the 
same.
In conclusion, the use of Intermittent preventive 
treatment with sulphadoxine-pyrimethamine and 
Insecticide treated nets is effective in prevention of 
malaria in pregnancy in non-malaria endemic region 
and is associated with reduction of adverse pregnancy 
outcomes. There is therefore a strong need to make 
the long lasting insecticide treated bed nets available 
for use by the pregnant women.
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